Hwa Kuang Biotech 2025 Q4 Financial Report
NQ Score
52/100
N1 Content Completeness
2
AI Summary (NQ-processed)
Hwa Kuang Biotech Co., Ltd. reported a net loss of NThBc179 million and basic EPS of NThBc2.68 for Q4 2025, with operating revenue reaching NT.839 billion.
AI analysis data is not yet available.